Jack L. Segal

1.3k total citations
47 papers, 1.1k citations indexed

About

Jack L. Segal is a scholar working on Pharmacology, Pathology and Forensic Medicine and Psychiatry and Mental health. According to data from OpenAlex, Jack L. Segal has authored 47 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 15 papers in Pathology and Forensic Medicine and 12 papers in Psychiatry and Mental health. Recurrent topics in Jack L. Segal's work include Spinal Cord Injury Research (14 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Stroke Rehabilitation and Recovery (6 papers). Jack L. Segal is often cited by papers focused on Spinal Cord Injury Research (14 papers), Antibiotics Pharmacokinetics and Efficacy (12 papers) and Stroke Rehabilitation and Recovery (6 papers). Jack L. Segal collaborates with scholars based in United States, United Kingdom and Canada. Jack L. Segal's co-authors include Sherry R. Brunnemann, Ibrahim M. Eltorai, Jane Hsieh, Patrick J. Potter, Keith C. Hayes, Alberta L. Warner, G A Delaney, Mayank Pathak, John F. Thompson and John F. Thompson and has published in prestigious journals such as Neurology, Antimicrobial Agents and Chemotherapy and Journal of the American Geriatrics Society.

In The Last Decade

Jack L. Segal

47 papers receiving 1.0k citations

Peers

Jack L. Segal

PFM

SURGE

CCM

PMH

PHARM

Frederick Frost United States

Patricia E. Watson New Zealand

Kris L. L. Movig Netherlands

Noor M. Gajraj United States

H. Haljamäe Sweden

P D’Athis France

John V. St. Peter United States

Tzu‐Ying Yu United States

Dennis Cordato Australia

R. W. Newton United Kingdom

Frederick Frost United States

Jack L. Segal

176 ×0.3

PFM

311 ×1.6

SURGE

83 ×0.5

CCM

159 ×1.1

PMH

205 ×1.5

PHARM

Citations per year, relative to Jack L. Segal Jack L. Segal (= 1×) peers Frederick Frost

Countries citing papers authored by Jack L. Segal

Since Specialization

Citations

This map shows the geographic impact of Jack L. Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack L. Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack L. Segal more than expected).

Fields of papers citing papers by Jack L. Segal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack L. Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack L. Segal. The network helps show where Jack L. Segal may publish in the future.

Co-authorship network of co-authors of Jack L. Segal

This figure shows the co-authorship network connecting the top 25 collaborators of Jack L. Segal. A scholar is included among the top collaborators of Jack L. Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack L. Segal. Jack L. Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Segal, Jack L., John F. Thompson, & Richard A. Charter. (2011). A Novel Immunogen to Modulate Cytokine Production and Promote Immune System Reconstitution in HIV–AIDS. American Journal of Therapeutics. 19(5). 317–323. 4 indexed citations

Segal, Jack L., et al.. (2003). Effects of 4‐Aminopyridine on Cardiac Repolarization, PR Interval, and Heart Rate in Patients with Spinal Cord Injury. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(2). 133–136. 14 indexed citations

Segal, Jack L., et al.. (1998). Methylprednisolone Disposition Kinetics in Patients with Acute Spinal Cord Injury. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(1). 16–22. 19 indexed citations

Segal, Jack L. & Sherry R. Brunnemann. (1998). 4-Aminopyridine Alters Gait Characteristics and Enhances Locomotion in Spinal Cord Injured Humans. Journal of Spinal Cord Medicine. 21(3). 200–204. 26 indexed citations

Warner, Alberta L., et al.. (1998). Heart rate variability is altered following spinal cord injury. Clinical Autonomic Research. 8(6). 329–334. 69 indexed citations

Potter, Patrick J., Keith C. Hayes, Jack L. Segal, et al.. (1998). Randomized Double-Blind Crossover Trial of Fampridine-SR (Sustained Release 4-Aminopyridine) in Patients With Incomplete Spinal Cord Injury. Journal of Neurotrauma. 15(10). 837–849. 74 indexed citations

Potter, Patrick J., Keith C. Hayes, Jane Hsieh, G A Delaney, & Jack L. Segal. (1998). Sustained improvements in neurological function in spinal cord injured patients treated with oral 4-aminopyridine: three cases. Spinal Cord. 36(3). 147–155. 51 indexed citations

Segal, Jack L., et al.. (1998). 4-Aminopyridine: Long-Term Administration to Spinal Cord Injured Humans Improves Sensorimotor Function and Is not Associated with Toxicity. Neurology. 51(1). 311–311. 1 indexed citations

Segal, Jack L., et al.. (1997). Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries. Archives of Physical Medicine and Rehabilitation. 78(1). 44–47. 87 indexed citations

10.

Segal, Jack L. & Sherry R. Brunnemann. (1997). 4‐Aminopyridine Improves Pulmonary Function in Quadriplegic Humans with Longstanding Spinal Cord Injury. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(3). 415–423. 55 indexed citations

11.

Segal, Jack L., et al.. (1996). Metoclopramide Increases the Bioavailability of Dantrolene in Spinal Cord Injury. The Journal of Clinical Pharmacology. 36(1). 64–71. 13 indexed citations

12.

Segal, Jack L., et al.. (1996). Reversal of Erythema Multiforme Major with Cyclophosphamide and Prednisone. Annals of Pharmacotherapy. 30(6). 606–607. 10 indexed citations

13.

Segal, Jack L., et al.. (1995). A NONPARAMETRIC ALTERNATIVE TO MODELING POPULATION PHARMACOKINETICS IN PATIENTS WITH SPINAL CORD INJURY. American Journal of Therapeutics. 2(2). 100–105. 2 indexed citations

14.

Segal, Jack L. & Sherry R. Brunnemann. (1993). Circulating Levels of Soluble Interleukin 2 Receptors Are Elevated in the Sera of Humans with Spinal Cord Injury. PubMed. 16(1). 30–33. 13 indexed citations

15.

Zhou, Xuehan, N.D. Vaziri, Jack L. Segal, et al.. (1993). Effects of Chronic Spinal Cord Injury and Pressure Ulcer on 25(OH)-Vitamin D Levels. PubMed. 16(1). 9–13. 26 indexed citations

16.

Segal, Jack L.. (1993). Spinal Cord Injury: Are Interleukins a Molecular Link between Neuronal Damage and Ensuing Pathobiology?. Perspectives in biology and medicine. 36(2). 222–240. 11 indexed citations

17.

Segal, Jack L., Sherry R. Brunnemann, Ibrahim M. Eltorai, & Michael Vulpe. (1991). Decreased Systemic Clearance of Lorazepam in Humans With Spinal Cord Injury. The Journal of Clinical Pharmacology. 31(7). 651–656. 21 indexed citations

18.

Brunnemann, Sherry R. & Jack L. Segal. (1991). Amikacin serum protein binding in spinal cord injury. Life Sciences. 49(2). PL1–PL5. 11 indexed citations

19.

Segal, Jack L., et al.. (1988). Amikacin Pharmacokinetics in Patients with Spinal Cord Injury. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 8(2). 79–81. 19 indexed citations

20.

Segal, Jack L., et al.. (1983). Gentamicin Disposition Kinetics in Humans With Spinal Cord Injury: A Preliminary Report. PubMed. 6(2). 41–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact